IVERIC bio Inc (ISEE)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

ONE PENN PLAZA NEW YORK, NY 10119

Ophthotech Corporation provides pharmaceutical treatments. The Company develops and markets therapies for back of the eye diseases.

Data as of 2020-11-22
Market Cap519.492 Million Shares Outstanding89.568 Million Avg 30-day Volume777.011 Thousand
P/E Ratio-4.6 Dividend Yield EPS-1.26
Price/Sales Price cash flow ratio24.0 Price free cash flow ratio-9.1
Book Value2.4 Price to Tangible Book2.42 Alpha0.01
Short Interest Ratio % Short Interest to Float R-squared0.033566
BETA1.63388 52-week High/Low8.97 / 2.64 Stddev0.375812

Are you looking for this stock instead?

View SEC Filings from ISEE instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 8 11 -27.27% 4 (0.26%) 6 (0.39%) -33.33%
Funds Holding: 101 120 -15.83% 39 (2.56%) 50 (3.24%) -22.0%
13F shares: 76.44 Million 76.674 Million -0.3% 53.273 Million 56.125 Million -5.08%
% Ownership 85.4056 86.649 -1.43% 59.521 63.4268 -6.16%
New Positions: 11 55 -80.0% 5 21 -76.19%
Increased Positions 48 33 45.45% 17 14 21.43%
Closed Positions 29 11 163.64% 16 4 300.0%
Reduced Positions 24 20 20.0% 12 12 0.0%
Total Calls 882.38 Thousand 242.27 Thousand 264.21% 141.5 Thousand 48.3 Thousand 192.96%
Total Puts 332.182 Thousand 194.007 Thousand 71.22% 88.4 Thousand 10.2 Thousand 766.67%
PUT/CALL Ratio 0.38 0.8 -52.5% 0.62 0.21 195.24%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ISEE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ISEE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BLUMENKRANZ MARK S.

  • Director
0 2020-07-15 2

CARROLL DAVID FRANCIS SVP, CFO AND TREASURER

  • Officer
33,707 2020-07-01 3

VERSANT VENTURE CAPITAL IV, L.P.

VERSANT SIDE FUND IV, L.P.

VERSANT VENTURES IV, LLC

  • 10% Owner
1,724,909 2020-06-19 1

BOLTE AXEL

  • Director
0 2020-06-09 1

HENDERSON JANE

  • Director
0 2020-06-09 1

GRAVES ADRIENNE L

  • Director
0 2020-06-09 1

ROBERTS CALVIN W.

  • Director
0 2020-06-09 1

DUGEL PRAVIN EVP, CHIEF STRATEGY & BUSINESS

  • Officer
0 2020-06-09 1

SBLENDORIO GLENN PRESIDENT AND CEO

  • Officer
  • Director
225,061 2020-04-01 3

GUYER DAVID R EXECUTIVE CHAIRMAN

  • Officer
  • Director
53,972 2020-01-04 3

WESTBY KEITH SVP & COO

  • Officer
40,983 2020-01-04 3

REDLICK DAVID E

  • Director
0 2019-05-15 0

ROSS MICHAEL JAY

  • Director
0 2018-05-23 0

WOOD BARBARA A SVP, GEN. COUNSEL, SECRETARY

  • Officer
16,462 2018-01-04 0

PATEL SAMIR CHANDRAKANT PRESIDENT

  • Officer
  • Director
15,813 2017-01-04 0

BJARKE HENRIC BJORN SVP & CCO

  • Officer
1,684 2017-01-04 0

NOVO A/S

  • 10% Owner
No longer subject to file 2016-12-14 0

SMITH IAN F

  • Director
0 2016-08-02 0

GALAKATOS NICHOLAS

  • Director
9,629 2016-01-11 0

ATIEH MICHAEL G EVP, CFO, & CBO, TREASURER

  • Officer
295 2016-01-02 0

CLARUS LIFESCIENCES II, L.P.

CLARUS VENTURES II GP, L.P.

CLARUS VENTURES II, LLC

GALAKATOS NICHOLAS

HENNER DENNIS

LIPTAK ROBERT

SIMON NICHOLAS

STEINMETZ MICHAEL

WHEELER KURT

  • Director
  • 10% Owner
No longer subject to file 2015-05-26 0

SMITH TODD N SVP & CCO

  • Officer
0 2015-01-02 0

PEACOCK BRUCE CFO & CBO

  • Officer
0 2014-09-02 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments